Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Inflammatory cells in orbital tissue refer to a collection of immune cells that infiltrate the orbital fat compartment and surrounding structures during inflammatory orbital diseases. These cells play an active role in the pathogenesis of various orbital inflammatory conditions. They include various immune cell types such as macrophages, T cells, B cells, and other inflammatory cells that diffusely infiltrate the orbital fat compartment. They are responsible for producing and releasing various pro-inflammatory mediators including pro-inflammatory cytokines (IL-6, TNF-α, IL-1β, IL-17A, IL-2, IL-8, IL-10, IL-12, and gamma interferon), fibrogenic growth factors, oxygen-free radicals, and glycosaminoglycans. These mediators act on orbital fat and surrounding tissues, stimulating various pathological processes including adipogenesis, fibroblast proliferation, and expression of immunomodulatory molecules.
Drugs targeting these cells or their mediators work by suppressing the immune response and inflammation, thereby reducing cellular infiltration and the production of pro-inflammatory mediators.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Orbital inflammatory cells.